Erratum to: The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries (Adv Ther, 10.1007/s12325-017-0522-y)

L. Gulácsi, V. Brodszky, P. Baji, F. Rencz, M. Péntek

Research output: Contribution to journalArticle (Academic Journal)peer-review

3 Citations (Scopus)
Original languageEnglish
JournalAdvances in Therapy
Early online date26 Apr 2017
DOIs
Publication statusPublished - 2017

Cite this